We investigated whether pre-germinated brown rice bran extract containing acylated steryl glucosides (PSG) reduces the risk of atherosclerosis in post-menopausal Vietnamese women. A total of 60 post-menopausal Vietnamese women (45-65 y old) with high LDL cholesterol levels (over 140 mg/dL) were randomly divided into PSG (n530) and placebo (n530) groups. The subjects in the PSG group were assigned a daily intake of 6 capsules containing 50 mg PSG, and the subjects in the placebo group were assigned a daily intake of 6 capsules containing corn oil for 6 mo. Before baseline and after month 2, month 4, and month 6 of the intervention, we conducted anthropometric measurements, blood biochemical examinations, a nutrition survey, and physical activity, flow-mediated dilation (FMD), and cardio-ankle vascular index (CAVI) measurements. Serum LDL cholesterol concentrations were significantly reduced from 163.6625.3 (mg/dL) to 135.9626.8 (mg/dL) compared to the placebo group (p,0.001). FMD values of the placebo group were significantly reduced from 6.665.1 (%) to 4.762.6 (%) compared to the PSG group (p,0.05). Tumor necrosis factor (TNF)-a concentrations in the PSG group were significantly reduced from 19.8611 (pg/mL) to 10.665.5 (pg/mL) compared to the placebo group (p,0.05). The findings suggest that PSG may improve LDL cholesterol, TNF-a levels, and FMD values. PSG might be considered in reducing the risk of atherosclerosis in post-menopausal Vietnamese women with high LDL cholesterol.
Atherosclerosis is the result of hyperlipidemia and lipid oxidation and has been increasing as a major cause of mortality in developed countries (1) . The exact causes and risk factors are unknown; however, certain conditions such as high LDL cholesterol levels, low HDL cholesterol levels, current smoking, and diabetes may raise the risk of developing atherosclerosis. Atherosclerosis is the process of narrowing and hardening of the arteries due to plaque buildup in the inner lining of the arteries. This is the key factor leading to cardiovascular diseases such as stroke and heart attack. According to Global Burden of Diseases 2010, more than 15% of mortality among Vietnamese people is related to atherosclerosis disease (stroke and ischemic heart diseases). It has been widely recognized that intake of whole grains such as brown rice or pre-germinated brown rice (PGBR) improves lipid metabolism (2) and reduces the risk of atherosclerosis (3) (4) (5) (6) . Pre-germinated brown rice is brown rice which has been slightly germinated by soaking brown rice in water. PGBR has become popular in Japan and the use of PGBR has been increasing in Vietnam during the last few years. The components of PGBR such as protein, carbohydrate, dietary fiber, vitamins and minerals are almost the same as those in brown rice. The process of germination increases components such as gammaaminobutyric acid (GABA) and acylated steryl glucosides (PSG). Furthermore, it has been confirmed that the PSG fraction extracted from PGBR bran promotes the activity of homocysteine thiolactone hydroxylase (HTLase) in diabetic rats (7) . Additionally, a study confirmed that PSG taken for 3 mo improved blood lipids in obese Japanese men with dyslipidemia (8) . However, the correlation of PSG and reduction of risk for atherosclerosis has not yet been described.
The present study was conducted to determine the effect of PSG on vascular endothelial function by using the flow-meditated dilation (FMD) method, metabolic parameters, and inflammatory parameters. It was decided to examine the effect of PSG on the risk of atherosclerosis in post-menopausal Vietnamese women with high LDL cholesterol levels.
MATERIALS AND METHODS
Setting and subjects study. The protocol of this study was approved by the ethics committee of the National Institute of Nutrition (NIN), Hanoi, Vietnam, before recruiting subjects. We screened 221 post-menopausal Vietnamese women living in Nam Dinh City. Nam Dinh City is in the Red River Delta of northern Vietnam, approximately 90 km from the capital, Hanoi. All subjects were fully informed concerning the process of the study, and the study was designed in conformity with the Helsinki Declaration on Human Studies. The study utilized a single-blind design. Eligibility criteria were post-menopausal women with high LDL cholesterol levels over 140 mg/dL. Exclusion criteria included the following: subjects who were taking medicines that controlled blood glucose or lipid metabolism; subjects who were suffering from serious heart disease, brain disease, kidney disease, liver disease, or gastrointestinal disease; subjects who had a history of smoking within the year prior to screening; subjects who were consuming pregerminated brown rice daily; subjects who had a body mass index (BMI) under 18.5; subjects who were not feeling well after starting the intervention. After screening, 60 subjects met the requirements.
The subjects were divided randomly into two groups: a PSG group (n530) and a placebo group (n530). The subjects in the PSG group received 6 PSG capsules (1.7 g) containing 50 mg PSG/d, and subjects in the placebo group took 6 placebo capsules (1.7 g) containing corn oil daily for 6 mo. The amounts of energy, lipid, and protein are almost equivalent for the placebo and PSG capsules. We used FANCL-manufactured PSG ® for PSG. All participants and providers were blind to the content of capsules. All subjects were advised to avoid change in their lifestyle, and no subjects were taking any medicines that affected cholesterol levels or bodyfat reduction during the time of the study.
All measurements and blood collection were conducted at the Nam Dinh Hospital of Endocrinology. We measured blood samples at a laboratory of NIN, Hanoi, Vietnam. Blood samples were taken after an overnight fast. The PSG and placebo groups were measured on the same day.
Anthropometric measurements. Weight, height, bodyfat percentage, waist and hip circumferences were measured four times. Body weight and height were measured in light clothing and without shoes. BMI was calculated as body weight per height squared (kg/m 2 ). Waist circumference was measured mid-way between the lower rib margin and the iliac crest, while hip circumference was measured at the broadest circumference around the buttocks. Body fat percentage was measured by the bioelectrical impedance method using the Omron scale (HBF-212b, Omron Co., Kyoto, Japan).
Nutrition survey. We used the 24 h recall method for a nutrition survey at baseline and completion. Energy and nutrient intake were measured based on the Vietnamese Food Composition Table 2007 (9) .
Physical activity. We gave pedometers to all subjects for 3 d; the result was calculated as average steps per day.
Blood sample collection. Blood samples were taken in the morning and after an overnight fast and were measured four times. Blood samples were kept frozen at 280˚C for analysis: HbA1c, total cholesterol, HDL cholesterol, LDL cholesterol, triacylglycerol and ELISA test. The ELISA test included: Human TNF-alpha quatikine HS ELISA (HSTA00D) and Human total Adiponectin/ Acrp30 quatikine ELISA kit (DRP300) (R&D Systems, Inc., Minneapolis, MN).
FMD method. Brachial artery FMD was assessed for vascular endothelial function by using high-resolution vascular echography (UNEXEF28G, UNEX, Nagoya, Japan). All subjects were measured for FMD in a quiet, air-conditioned room (the room temperature at 25˚C). The participants had to rest before and during measurements for about 20 min. First of all, the technician used the probe holder looking for a good position of the brachial artery as indicated on the monitor and then recorded artery diameter at baseline. In addition, systolic blood pressure, diastolic blood pressure and heart rate were measured. Secondly, arterial occlusion was created by pumping pressure into the forearm (50 mmHg higher than systolic blood pressure) and that pressure was maintained for 5 min. After releasing pressure at the forearm, the probe detector scanned continuous measurement of the peak of arterial diameter for 2 min. FMD was calculated as the percentage of artery diameter change in response to the forearm hyperemic stimulus.
FMD value5 (Brachial artery at maximum2Bra-chial artery at baseline) * 100/Brachial artery at baseline (10). The FMD value for women aged from 50-59 y old is presented below (11) .
Normal FMD value $6%. Risk of atherosclerosis at FMD value,6%. Cardio-ankle vascular index (CAVI) method. CAVI was measured using a VeSera CAVI instrument (Fukuda Denshi Co. Ltd., Tokyo, Japan). Briefly, cuffs were applied to bilateral upper arms and ankles, with the subjects lying supine and the head held in the midline position. Examinations were performed after resting for 10 min. To detect brachial and ankle pulse waves with cuffs, a low cuff pressure from 30 to 50 mmHg was used to ensure the minimal effect of cuff pressure on hemodynamics. Blood pressure was measured thereafter. CAVI was calculated by using the following formula: CAVI5a{(2/DP)3In(Ps/Pd) PWV²}1b where Ps is systolic blood pressure, Pd is diastolic blood pressure, and PWV is obtained by dividing the vascular length by the time for which the pulse wave is propagated from the aortic valve to the ankle. It is measured by the cuffs on the upper arms and ankles. This is compatible with the aortic PWV method, established by Hasegawa and coworkers. Scale conversion constants (a, b) are determined so as to match CAVI with the aortic PWV method. By scale conversion constants, massive previous data for PWV could be converted to CAVI; all these measurements and the calculation system were combined and automatically calculated in Vasera. The average coefficient of variation for CAVI was less than 5%, which was small enough for clinical use and indicated that CAVI has good reproducibility (12) .
Statistical analysis. Data were analyzed by using JMP version 11 (SAS Institute Inc., Cary, NC). We calculated change in percentage for each item at completion and baseline. All items of the PSG and placebo groups were compared using an unpaired t-test, and data at baseline and completion were compared using a paired t-test. Items with confirmed homoscedasticity were compared by Student's t-test and those with no confirmed homoscedasticity by using Welch's t-test. p values of less than 0.05 were considered statistically significant for all analyses.
RESULTS

Subjects
Fifty-five subjects completed the study; 4 subjects from the placebo group and 1 subject from the PSG group withdrew from the study, due to personal reasons. All subjects completed over 90% of the study process. No subjects in either group had any symptoms related to the intake of test substances. Table 1 shows the amount of weight, protein, lipid, carbohydrate, energy, ash, sodium, and acylated steryl glucoside extract from pre-germinated brown rice bran of the 6 PSG capsules and 6 placebo capsules. Table 2 shows the baseline parameters of both groups. There were no significant differences in parameters for age, height, weight, body fat percentage, systolic blood pressure, diastolic blood pressure, abdominal circumference, FMD value, CAVI value, total cholesterol, LDL cholesterol, HDL cholesterol, HbA1c, or triacylglycerol between the PSG and the placebo groups. Only hip circumference of the PSG group was significantly higher than that of the placebo group (p,0.05).
Nutrition facts for PSG and placebo capsules
Baseline characteristics
Physical characteristics
In Table 3 , we indicate the physical activity, FMD and CAVI at all intervention times. No significant difference was observed between the placebo and PSG groups in BMI, body fat percentage, abdominal circumference, hip, CAVI, systolic blood pressure or diastolic blood pressure. Only FMD of the PSG group differed significantly from the placebo group at 2 mo, 4 mo, and 6 mo (Fig.  1 ). There were significant reductions in body fat percentage, abdominal circumference, and hip circumference of the PSG group between baseline and completion (p,0.05). There was a significant reduction in body fat percentage (p,0.05) and an increase in BMI of the placebo group between baseline and completion. And there was a small reduction in BMI of the PSG group between baseline and completion.
Blood biochemical parameters Table 4 shows results of blood tests at month 6 of the intervention, and the percent change between completion and baseline. No significant difference was observed between the placebo and PSG groups in total cholesterol, HDL cholesterol, or triacylglycerol. LDL cholesterol was significantly different between the placebo and PSG groups at 4 mo and 6 mo (Fig. 2) . HbA1c and LDL-C/HDL-C ratios were also significantly different between the PSG and placebo groups at 6 mo. Both groups were significantly different in total cholesterol and triacylglycerol when comparing baseline and completion. HDL cholesterol of the placebo group showed significant reduction from baseline to completion. Percentage of change from baseline to completion of LDL cholesterol, LDL-C/HDL-C ratio and HbA1c in the PSG group showed a significant difference compared with the placebo group. Table 5 shows amount of energy and nutrient intake and physical activity of both groups at baseline and completion; there were no significant differences in energy, lipid, carbohydrate, fiber or physical activity (steps) between the PSG and placebo groups at baseline or completion. Both groups showed significant reduction in fiber and physical activity at the final measurement. Only protein intake of the PSG group at base- line was significantly different from that of the placebo group (p,0.05). Table 6 shows the results of serum adiponectin and tumor necrosis factor (TNF)-a for both groups. In the PSG group, serum adiponectin was significantly increased and TNF-a was significantly reduced at 4 mo and 6 mo (p,0.05). Serum TNF-a was significantly different compared with the placebo group at 4 mo and 6 mo (Fig. 3) .
Energy and nutrient intakes and physical activity
ELISA test
DISCUSSION
The study examined the effects of PSG on postmenopausal Vietnamese women in a 6-mo intervention. Our main findings were that PSG is correlated with FMD values, LDL cholesterol, and TNF-a. Firstly, menopause is the one of most significantly events in a woman's life and it causes a variety of symptoms that appear before, during and after the onset on menopause. The major reason leading to menopause maybe defined as a decrease in hormone production by the ovaries, particularly of estrogen. Some studies have indicated increased risk factors of atherosclerosis in women after menopause (13, 14) . The results of physical measurements showed a BMI increase in the placebo group from baseline (22. ). The changing gap in BMI in the placebo and PSG groups was very small. The abdominal and hip circumferences of the PSG group decreased from baseline values of 82.466.5 cm and 91.064.5 cm to the final 80.565.7 cm and 87.765.0 cm. Those in the placebo group showed a small decrease from baseline (82.067.6 cm and 88.865.6 cm) to completion (81.767.9 cm and 87.664.6 cm). There was a greater reduction in abdominal and hip circumference for the PSG group compared to the placebo group, but the decrease in this difference between baseline and completion was small. Both groups significantly fell in body fat percentage from baseline 35.263.8% (PSG) and 34.465.3% (placebo) to the final 31.863.9% (PSG) and 32.064.8% (placebo). Body fat percentage is a very sensitive indicator and is affected by many factors such as measurement methods, energy intake, physical activity, and even time of day. Moreover, the PSG subjects utilized 50 mg PSG/d, an amount equivalent to about 300-500 g (2-3 servings) of boiled PGBR or brown rice. In some studies that have been conducted with Taiwanese (15) and Vietnamese (16) subjects, an improvement in lipid metabolism and reduction in body circumference was observed by replacing white rice with PGBR in two of the subjects' meals per day. However, the effect of PSG on body fat percentage, and body weight are not clear in present study.
A main finding is that LDL cholesterol levels in the PSG group were significantly reduced after the 6-mo intervention, while those in the placebo group were unchanged. Similar to our results, a previous study in obese Japanese men with 3-mo PSG intake reported that the PSG group also experienced a significant reduction in LDL cholesterol levels and their abdominal circumference showed a small reduction but their BMI was unchanged (8) . It might prove to be the case that PSG reduces LDL cholesterol over longer periods of time. There are some epidemiological studies that have shown a correlation between increasing LDL cholesterol and a rise in the risk of atherosclerosis disease (17) (18) (19) (20) . Atherosclerosis is usually characterized by disorders in lipid metabolism, leading to LDL cholesterol deposition on arterial walls, which is associated with an inflammatory response and results in plaque formation (21) . Additionally, convincing experimental evidence has implicated LDL cholesterol as a special contributor to the atherogenic process (22) (23) (24) . Initiation of the atherogenic process may occur in response to some form of endothelial cell injury. This injury could result from mechanical stress such as hypertension or high levels of oxidized LDL, which is known to be toxic to endothe- 3) Macrophages stimulated by the uptake of LDL cholesterol release additional growth factors and chemotactic factors (cytokines) that attract more macrophages to the site, creating more foam cells. Most of the lipid in foam cells is cholesterol and cholesterol esters. As the foam cells proliferate, their lipid contents accumulate in the form of fatty streaks. These ultimately enlarge, occluding, to a degree, the arterial lumen, which can become narrowed to the extent that blood flow is compromised. Our primary finding was that FMD values were not significantly different between the two groups at baseline. However, FMD values in the two groups were significantly different at month 2 to month 6 of the intervention. Additionally, increased FMD has been reported to be associated with improvement in risk factors for atherosclerosis (25) (26) (27) . In a cross-over study, it was observed that brown rice might improve FMD values (28) . Some of the above results suggest FMD values and LDL cholesterol might be correlated and both related to atherosclerosis disease. Furthermore, one study found that high whole-grain intake was associated with less atherosclerosis progression in post-menopausal women with established heart disease (29) . Longitudinal studies have consistently shown higher intakes of whole grain to be associated with lower cardiovascular disease risks, with a risk reduction of about 25% when the high and low groups of intake were compared (3-5). Whole grain contains endosperm, bran and germ layers, the two components which are removed during the refining process; PSG is made from rice bran extract. This may explain why PSG is one factor in reducing the risk of atherosclerosis disease.
Our other finding was that PSG intake was associated with TNF-a level. To our knowledge, this is the first finding of an association between PSG and TNF-a level in human studies. In an animal study, the results also showed the reduction of TNF-a in a PSG mouse group (manuscript in preparation). TNF-a is a cytokine secreted by both immune cells and adipocytes. Reports have shown that whole-grain intake is associated with less inflammation and that people who frequently consume whole grains have lower inflammation (30) . Furthermore, serum adiponectin levels in the PSG group were significantly increased, while those in the placebo group increased only slightly after the 6-mo intervention. Some studies have shown an inverse correlation between LDL cholesterol and adiponectine (31) (32) (33) (34) . It might make sense that the adequate level of LDL cholesterol in the PSG group decreased, while adiponectine in the PSG group increased after the 6-mo intervention. Moreover, adiponectin levels are also significantly lower in patients with coronary artery disease than in matched control subjects (35, 36) . From the evidence above, it may be possible to conclude that PSG intake improves inflammation in post-menopausal Vietnamese women. The dietary survey and physical activity showed that final intake of fiber and physical activity were reduced, but this may be because the study began in the winter and concluded in the summer, with just 3 d selected for the dietary survey and 3 d measured for physical activity. These surveys were very brief and did not reflect the whole intervention period. Limitations of this study were that the mechanism of PSG on LDL cholesterol, FMD value and TNF-a are still unknown. This suggests research for discovering the mechanism of PSG in future studies.
In conclusion, PSG intake was associated with FMD values, LDL cholesterol levels, TNF-a and adiponectin levels. These findings suggest that PSG may reduce the risk of atherosclerosis in post-menopausal Vietnamese women with high LDL cholesterol levels.
